We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.53B
AUM Growth
+$93.1M
(+1.1%)
Cap. Flow
+$472M
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
812
New
193
Increased
197
Reduced
149
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$188M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
Electronic Arts
EA
|
+$112M |
| 4 |
Autodesk
ADSK
|
+$97.3M |
| 5 |
Keysight
KEYS
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$123M |
| 2 |
Amphenol
APH
|
+$113M |
| 3 |
Cencora
COR
|
+$108M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
HP
HPQ
|
+$91.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.52% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Kenvue
KVUE
$37.8B
| $9.71M | 0.11% |
483,516
-231,457
| -32% | -$5.36M |
|
227
nCino
NCNO
$2.11B
| $9.64M | 0.11% |
303,254
+287,470
| +1,821% | +$8.87M |
|
228
Arbutus Biopharma
ABUS
$913M
| $9.58M | 0.11% |
4,719,903
+2,250,706
| +91% | +$4.72M |
|
|
VRNA
229
DELISTED
Verona Pharma
VRNA
| $9.56M | 0.11% |
586,722
+86,722
| +17% | +$1.67M |
|
230
CAVA Group
CAVA
$7.71B
| $9.52M | 0.11% |
310,766
+103,650
| +50% | +$4.52M |
|
231
Avery Dennison
AVY
$13.3B
| $9.41M | 0.11% |
51,497
+34,755
| +208% | +$6.29M |
|
232
Ralph Lauren
RL
$22.7B
| $9.41M | 0.11% |
81,019
+49,197
| +155% | +$5.96M |
|
|
LSXMA
233
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $9.39M | 0.11% |
368,879
-1,073,810
| -74% | -$25.4M |
|
234
Lattice Semiconductor
LSCC
$18.2B
| $9.38M | 0.11% |
+109,198
| New | +$9.86M |
|
|
SLRN
235
DELISTED
ACELYRIN
SLRN
| $9.23M | 0.11% |
907,913
-127,642
| -12% | -$2.71M |
|
236
Xponential Fitness
XPOF
$280M
| $9.11M | 0.11% |
587,549
+198,848
| +51% | +$3.9M |
|
237
Olema Pharmaceuticals
OLMA
$1.01B
| $8.86M | 0.1% |
717,332
+129,280
| +22% | +$1.32M |
|
238
Cheesecake Factory
CAKE
$5.24B
| $8.83M | 0.1% |
+291,550
| New | +$9.72M |
|
239
Viatris
VTRS
$20.6B
| $8.77M | 0.1% |
889,113
+76,613
| +9% | +$798K |
|
240
ATI
ATI
$28B
| $8.76M | 0.1% |
212,877
-231,797
| -52% | -$10.3M |
|
|
CCRN
241
DELISTED
Cross Country Healthcare
CCRN
| $8.72M | 0.1% |
+351,720
| New | +$8.85M |
|
242
Structure Therapeutics
GPCR
$3.59B
| $8.57M | 0.1% |
170,000
| – | – |
|
|
CYBR
243
DELISTED
CyberArk
CYBR
| $8.5M | 0.1% |
51,931
-71,105
| -58% | -$11.4M |
|
|
BLUE
244
DELISTED
bluebird bio
BLUE
| $8.3M | 0.1% |
136,437
+97,292
| +249% | +$6.83M |
|
245
Samsara
IOT
$22.6B
| $8.25M | 0.1% |
+327,338
| New | +$8.68M |
|
246
Advance Auto Parts
AAP
$3.59B
| $8M | 0.09% |
143,065
+59,012
| +70% | +$3.95M |
|
|
CEM
247
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $7.95M | 0.09% |
225,745
| – | – |
|
|
SLNO
248
DELISTED
Soleno Therapeutics
SLNO
| $7.79M | 0.09% |
+263,860
| New | +$1.6M |
|
249
Phathom Pharmaceuticals
PHAT
$666M
| $7.67M | 0.09% |
740,021
+66,333
| +10% | +$910K |
|
250
Harmony Biosciences
HRMY
$2.23B
| $7.66M | 0.09% |
233,859
-6,357
| -3% | -$221K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Woodline Partners held 812 positions worth $8.53B, up 1.1% from $8.44B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $472M of net new capital in Q3 2023, opening 193 new positions and adding to 197 existing holdings. Its largest new stake was Analog Devices: 1,016,972 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Hess, an estimated $123M trimmed.
- Woodline Partners's largest Q3 2023 buy was Analog Devices: 1,016,972 shares worth $178M.
- Woodline Partners added most to AbbVie in Q3 2023, an estimated $121M increase.
- Woodline Partners's biggest Q3 2023 reduction was Hess, cutting an estimated $123M.
- Woodline Partners fully exited HP in Q3 2023, selling an estimated $91.2M.
- Woodline Partners's ten largest holdings make up 17% of its $8.53B portfolio in Q3 2023.
- Woodline Partners opened 193 new positions and closed 231 in Q3 2023.
- Woodline Partners's portfolio value rose 1.1% quarter-over-quarter to $8.53B.
Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.